Keynote Speakers


This years conference keynote speakers will be focusing on the future of Healthcare and the changing role of the statistician to account for this.

PSI keynote speaker 1

Dr. Nupur Kohli

Medical Doctor, Advisor Healthcare, Global Speaker, Researcher, Author

In the coming future healthcare will face a big pressure due to the changing demographics of the world.

In this talk Dr. Kohli will highlight the current challenges in the healthcare delivery system and share learnings from global experiences in the current healthcare system. She will also share opportunities, new developments and the impact new implementations will have for the future.

As technology improves every day, new developments are constantly changing the dynamics of the healthcare sector. Can the healthcare sector keep pace? And how are the Netherlands and Europe dealing with the changes?

About this and more Dr. Kohli will talk presenting both from the healthcare providers and healthcare receivers point of view.


  • Winner of the VIVA400 Award for Most Inspiring Woman of the Netherlands 2016 in the category Smart Brains.
  • Winner of one of the 50 most inspiring women in technology the Netherlands, Europe, by Inspiring Fifty Europe.
  • Winner of the TEDx best speaker Award in Delft in 2012.

    Nupur has obtained her M.D. title at the Academic Medical Center in Amsterdam and has studied Fundamentals of Business at Harvard Business School, USA. As an internationally recognized speaker, Nupur has given more than 80 speeches worldwide over the past few years. In 2012 she gave her first TEDx Talk to an audience of 1000 plus in Delft. In 2016 she gave her second TEDx Talk at Nyenrode Business University. She featured on national television, radio and in newspapers in the Netherlands and in more than two dozen other prominent print and online media around the world.
    She worked as a strategic management advisor for healthcare at Ernst and Young and is a community pediatrician.
    Nupur is a trend-spotter in healthcare with a special interest in Europe and Asia. She regularly
    interacts with decision makers in the healthcare Industry. Her other interest is to reduce stress in
    societies and corporates, which influences decision making, productivity and profitability. She has done significant research on stress and productivity and is the author of the book ‘Chill! How to survive stress and improve personal and professional productivity. Symptoms and solutions to
    chronic pressure’.
PSI keynote speaker 2

Steve Ruberg

President of Analytix Thinking, LLC

The world is exploding with data, and the application of ‘analytics’ is growing at a commensurate rate. The question remains: “Are we using the right data and are we applying smart analytics?” This talk will explore statistics versus data science and highlight how statisticians in the pharmaceutical industry can reinvent themselves to play a much broader role in their companies than the historical role in clinical development or R&D. It will also the value of statistics beyond data science, and encourage statisticians as well as our profession to insure we communicate our value appropriately.


Stephen J. Ruberg, PhD is President of Analytix Thinking, LLC, a consulting company focused on strategic and technical consulting for drug development as well as teaching statistical concepts to non-statisticians. Previously, Dr. Ruberg was a Distinguished Research Fellow and Scientific Leader, Advanced Analytics, Eli Lilly & Company. He is also Adjunct Professor of Statistics at Purdue University. In the pharmaceutical industry since 1981, he has been an industry leader in the development and application of statistical methods in drug development as well as advances in data management and eClinical technology.  He has published widely in statistical, scientific, and industry trade journals and is a frequent speaker at statistical and scientific conferences. Among other awards and recognitions, in 1994, he was elected a Fellow of the American Statistical Association (ASA) and in 2012 received the Career Achievement Award from Quantitative Scientists in the Pharmaceutical Industry (QSPI).

Dr. Ruberg was Deputy Chair for the ICH Expert Working Group that published the ICH-E9 document Statistical Principles for Clinical Trials.  He received the FDA Commissioner's Special Citation for his work on electronic NDAs. He was on the Executive Committee of the ASA Biopharmaceutical Section and was Chair of the PhRMA Biostatistics and Data Management Steering Committee.  He was the first Chairman of the Board of Directors for the Clinical Data Interchange Standards Consortium (CDISC) and was actively involved with CDISC for its first seven years. In the past, he served as Chair of the Board of Trustees of the Mathematical Biosciences Institute at The Ohio State University, and was appointed by the Secretary of Health and Human Services (HHS) to the board of directors for the National eHealth Collaborative, which was working to create the Nationwide Health Information Network. 

Dr. Ruberg received a BA in Mathematics from Thomas More College, an MS in Statistics from Miami University in Ohio, and a PhD in Biostatistics from the University of Cincinnati.

Website Banner Template

Latest News

Show all news

EventsFuture Events

  • PSI Toxicology SIG Webinar - Dates: 19 – 19 Jun, 2018

    Ludwig A. Hothorn will be presenting on recent developments of statistics in toxicology - using R.
  • IDEAS Dissemination Workshop - Dates: 26 Sep, 2018

    The aim of the workshop is to translate and promote novel methodologies developed by IDEAS and is geared towards statisticians and trialists with an interest in novel methods for early phase clinical trials. Therefore, it will be of interest to those working in academia, industry, HTA or regulatory authorities.

Head of Biostatistics & Data Management






Principal Statistician



Principal Biostatistician



Head, Statistical Modelling & Simulation Services